Briefing: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales

Strategic angle: Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug.

by Editorial Staff|Mar 9, 2026|1 MIN READ|WORLD

Summary

  • Summary pending editorial review.

Key Facts

  • Key facts pending editorial review.

Sources